News Headlines Article

HRSA rule clarifies hospitals’ ability to purchase orphan drugs at discount
Modern Healthcare

A new regulation will allow certain hospitals to buy orphan drugs at deeply discounted prices if they’re used to treat non-orphan conditions or diseases. The rule, issued earlier this week by the Health Resources and Services Administration, seeks to clarify a statute that excluded these facilities from purchasing drugs designated for a rare disease or condition at 340B prices. The 340B federal drug discount program requires drug manufacturers to provide eligible healthcare providers with discounts on what are called covered outpatient drugs.